- Home
- ERAS vs BHK Comparison
ERAS vs BHK Comparison
Compare ERAS & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- BHK
- Stock Information
- Founded
- ERAS 2018
- BHK 2001
- Country
- ERAS United States
- BHK United States
- Employees
- ERAS N/A
- BHK N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- BHK Finance Companies
- Sector
- ERAS Health Care
- BHK Finance
- Exchange
- ERAS Nasdaq
- BHK Nasdaq
- Market Cap
- ERAS 723.8M
- BHK 609.2M
- IPO Year
- ERAS 2021
- BHK N/A
- Fundamental
- Price
- ERAS $2.49
- BHK $10.73
- Analyst Decision
- ERAS Strong Buy
- BHK
- Analyst Count
- ERAS 5
- BHK 0
- Target Price
- ERAS $5.90
- BHK N/A
- AVG Volume (30 Days)
- ERAS 1.2M
- BHK 188.3K
- Earning Date
- ERAS 11-12-2024
- BHK 01-01-0001
- Dividend Yield
- ERAS N/A
- BHK 8.34%
- EPS Growth
- ERAS N/A
- BHK N/A
- EPS
- ERAS N/A
- BHK 1.03
- Revenue
- ERAS N/A
- BHK N/A
- Revenue This Year
- ERAS N/A
- BHK N/A
- Revenue Next Year
- ERAS N/A
- BHK N/A
- P/E Ratio
- ERAS N/A
- BHK $10.42
- Revenue Growth
- ERAS N/A
- BHK N/A
- 52 Week Low
- ERAS $1.64
- BHK $9.02
- 52 Week High
- ERAS $3.45
- BHK $11.09
- Technical
- Relative Strength Index (RSI)
- ERAS 38.71
- BHK 30.32
- Support Level
- ERAS $2.51
- BHK $11.16
- Resistance Level
- ERAS $2.68
- BHK $11.29
- Average True Range (ATR)
- ERAS 0.22
- BHK 0.10
- MACD
- ERAS -0.05
- BHK -0.02
- Stochastic Oscillator
- ERAS 10.00
- BHK 1.21
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About BHK Blackrock Core Bond Trust
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its managed assets in bonds that are investment-grade quality at the time of investment. The trust's investments will include a broad range of bonds, including corporate bonds, U.S. government and agency securities and mortgage-related securities.